Similar Articles
121 Hypofractionated and intensity-modulated radiotherapy combined with systemic therapy in metastatic hepatocellular carcinoma: A case report
122 Improving clinical outcomes of patients with hepatocellular carcinoma: Role of antiviral therapy, conversion therapy, and palliative therapy
123 Multidisciplinary approaches in the management of advanced hepatocellular carcinoma: Exploring future directions
124 Intratumoural microorganism can affect the progression of hepatocellular carcinoma
125 Clinical significance of upregulated Rho GTPase activating protein 12 causing resistance to tyrosine kinase inhibitors in hepatocellular carcinoma
126 Impact of baseline body mass index on the long-term prognosis of advanced hepatocellular carcinoma treated with immunotherapy
127 Conversion therapy for hepatocellular carcinoma to improve treatment strategies for intermediate and advanced stages
128 Liver transplantation following two conversions in a patient with huge hepatocellular carcinoma and portal vein invasion: A case report
129 Advancing prognostic understanding in hepatocellular carcinoma through the integration of genomic instability and lncRNA signatures: GILncSig model
130 Transjugular intrahepatic portosystemic shunt for esophagogastric variceal bleeding in patients with hepatocellular carcinoma and portal vein tumor thrombus
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA